Comparison of Total and Segmental Body Composition Using DXA and Multifrequency Bioimpedance in Collegiate Female Athletes
Overview
Authors
Affiliations
The purpose of this investigation was to determine the agreement between multifrequency bioelectrical impedance analysis (BIA) and dual-energy x-ray absorptiometry (DXA) for measuring body fat percentage (BF%), fat-free mass (FFM), and total body and segmental lean soft tissue (LST) in collegiate female athletes. Forty-five female athletes (age = 21.2 ± 2.0 years, height = 166.1 ± 7.1 cm, weight = 62.6 ± 9.9 kg) participated in this study. Variables measured through BIA and DXA were as follows: BF%, FFM, and LST of the arms (ARMS(LST)), the legs (LEGS(LST)), the trunk (TRUNK(LST)), and the total body (TOTAL(LST)). Compared with the DXA, the InBody 720 provided significantly lower values for BF% (-3.3%, p < 0.001) and significantly higher values for FFM (2.1 kg, p < 0.001) with limits of agreement (1.96 SD of the mean difference) of ±5.6% for BF% and ±3.7 kg for FFM. No significant differences (p < 0.008) existed between the 2 devices (InBody 720-DXA) for ARMS(LST) (0.05 kg), TRUNK(LST) (0.14 kg), LEGS(LST) (-0.4 kg), and TOTAL(LST) (-0.21 kg). The limits of agreement were ±0.79 kg for ARMS(LST), ±2.62 kg for LEGS(LST), ±3.18 kg for TRUNK(LST), and ±4.23 kg for TOTAL(LST). This study found discrepancies in BF% and FFM between the 2 devices. However, the InBody 720 and DXA appeared to provide excellent agreement for measuring total body and segmental LST. Therefore, the InBody 720 may be a rapid noninvasive method to assess LST in female athletes when DXA is not available.
Key Performance Indicators for College American Football Starters: An Exploratory Study.
Johnson Q, Yang Y, Cabarkapa D, Stock S, Gleason D, Akehi K J Funct Morphol Kinesiol. 2025; 10(1.
PMID: 39846660 PMC: 11755533. DOI: 10.3390/jfmk10010019.
Looney D, Schafer E, Chapman C, Pryor R, Potter A, Roberts B Front Nutr. 2024; 11:1491931.
PMID: 39691170 PMC: 11649400. DOI: 10.3389/fnut.2024.1491931.
Kim Y, Kim D, Kim J, Yun M, Kang E ESC Heart Fail. 2024; 12(1):467-476.
PMID: 39344859 PMC: 11769618. DOI: 10.1002/ehf2.15086.
Lai Y, Ho C, Huang A, Lu H, Hsieh K PLoS One. 2024; 19(8):e0300911.
PMID: 39196957 PMC: 11356429. DOI: 10.1371/journal.pone.0300911.
Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.
Rodriguez Jimenez B, Rodriguez de Vera Gomez P, Belmonte Lomas S, Mesa Diaz A, Caballero Mateos I, Galan I Front Endocrinol (Lausanne). 2024; 15:1386542.
PMID: 38894744 PMC: 11182984. DOI: 10.3389/fendo.2024.1386542.